Crossmark

Successful treatment of MPO-ANCA positive crescentic IgA nephropathy/IgA vasculitis with nephritis potentially triggered by a COVID-19 vaccine in a young adult female using corticosteroids, rituximab, and avacopan

Crossref DOI link: https://doi.org/10.1007/s13730-025-00991-6

Published Online: 2025-04-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kaseda, Ken

Terakawa, Ryou

Matsui, Rena

Yasukawa, Minoru

Asakawa, Shinichiro

Arai, Shigeyuki

Yamazaki, Osamu

Tamura, Yoshifuru

Ohashi, Ryuji

Shibata, Shigeru

Fujigaki, Yoshihide https://orcid.org/0000-0003-2803-9161
License Information

Text and Data Mining valid from 2025-04-09

Version of Record valid from 2025-04-09
More Information

Article History

Received: 16 November 2024

Accepted: 21 March 2025

First Online: 9 April 2025

Declarations

:

: The authors have declared that no conflict of interest exists.

: This article does not contain any studies with human participants performed by any of the authors.

: Written informed consent was obtained from the patient.

Document is current

Any future updates will be listed below